Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGINTERFERON LAMBDA-1A for Antiviral treatment: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where PEGINTERFERON LAMBDA-1A was used for Antiviral treatment.

Most Reported Side Effects for PEGINTERFERON LAMBDA-1A

Side Effect Reports % Deaths Hosp.
Jaundice 18 25.7% 2 6
Rash 18 25.7% 5 11
Alanine aminotransferase increased 8 11.4% 0 2
Aspartate aminotransferase increased 8 11.4% 0 2
Hyperbilirubinaemia 7 10.0% 1 2
Pyrexia 7 10.0% 6 4
Ascites 6 8.6% 6 3
Haemoglobin decreased 6 8.6% 1 2
Hepatic failure 6 8.6% 6 3
Sleep disorder 6 8.6% 0 6
Affective disorder 5 7.1% 0 5
Cholestasis 5 7.1% 5 2
Dizziness 5 7.1% 0 5
Encephalopathy 5 7.1% 5 2
Epilepsy 5 7.1% 0 5

Other Indications for PEGINTERFERON LAMBDA-1A

Chronic hepatitis c (60) Hepatitis c (5)

Other Drugs Used for Antiviral treatment

ACYCLOVIR (230) RIBAVIRIN (150) RITONAVIR (95) VALGANCICLOVIR (94) LOPINAVIR\RITONAVIR (89) GANCICLOVIR (88) LAMIVUDINE (77) VALACYCLOVIR (77) NIRMATRELVIR\RITONAVIR (74) SOFOSBUVIR (73)

Related Pages

PEGINTERFERON LAMBDA-1A Full Profile All Antiviral treatment Drugs PEGINTERFERON LAMBDA-1A Demographics PEGINTERFERON LAMBDA-1A Timeline